A novel high-performance liquid chromatographic method combined with fluorescence detection for determination of ertugliflozin in rat plasma: Assessment of pharmacokinetic drug interaction potential of ertugliflozin with mefenamic acid and ketoconazole

A novel high-performance liquid chromatographic method combined with fluorescence detection for determination of ertugliflozin in rat plasma: Assessment of pharmacokinetic drug interaction potential of ertugliflozin with mefenamic acid and ketoconazole

Innovative Grade US Origin Rat Sprague Dawley Plasma from Innovative Research was used in the following study:

 

A novel high-performance liquid chromatographic method combined with fluorescence detection for determination of ertugliflozin in rat plasma: Assessment of pharmacokinetic drug interaction potential of ertugliflozin with mefenamic acid and ketoconazole

Dong-Gyun Han, Hwayoung Yun, In-Soo Yoon

Journal of Chromatography B
25 May 2019

“…Type 2 diabetes mellitus (T2DM) is a metabolic disorder characterized by insulin resistance and the inability of the body to secrete sufficient insulin, resulting in high blood glucose levels [1]. A recent survey estimated that T2DM affected 415 million adults worldwide in 2015; this number is expected to increase to 642 million by 2040 …Pooled plasma from male Sprague-Dawley rats was purchased from Innovative Research, Inc. (Novi, MI, USA)…”

 

Related products available from Innovative Research also include: